Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-08-08 | 2017-09-22 | 18543 |
| APO-FELODIPINE | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-01-09 | 2025-01-31 | 247394 |
| APO-FELODIPINE | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-01-09 | 2025-01-24 | 247391 |
| APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-19 | 2024-02-09 | 216662 |
| APO-FELODIPINE | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-24 | 2024-02-09 | 211484 |
| APO-FINASTERIDE | 5MG | TABLET | Resolved | 2019-04-04 | 2019-08-02 | 80533 |
| APO-FINASTERIDE | 5MG | TABLET | Resolved | 2017-06-19 | 2017-07-19 | 13317 |
| APO-FINASTERIDE | 5MG | TABLET | Resolved | 2019-09-12 | 2019-10-01 | 93671 |
| APO-FINASTERIDE | 5MG | TABLET | Actual shortage | 2024-01-19 | 2024-02-16 | 216684 |
| APO-FINGOLIMOD | 0.5MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-05-10 | 216744 |
| APO-FLAVOXATE | 200MG | TABLET | Actual shortage | 2017-08-14 | 2017-10-05 | 19117 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2024-01-05 | 2024-02-16 | 215218 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2023-09-01 | 2023-09-07 | 203539 |
| APO-FLECAINIDE | 100MG | TABLET | Resolved | 2024-10-31 | 2024-12-13 | 241691 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2024-11-29 | 2024-12-13 | 244200 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2022-06-27 | 2022-09-06 | 163445 |
| APO-FLECAINIDE | 100MG | TABLET | Resolved | 2019-10-23 | 2019-11-04 | 97048 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2019-10-23 | 2019-11-04 | 97051 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2025-08-21 | 2025-10-31 | 265817 |
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2021-01-08 | 2021-01-20 | 131160 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2018-09-08 | 2018-09-08 | 60753 |
| APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |
| APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
| APO-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60775 |
| APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60772 |
| APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-07-13 | 60758 |
| APO-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60766 |
| APO-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2019-02-05 | 60778 |
| APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60763 |
| APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60769 |
| APO-SALVENT TABLETS - 2MG | 2MG | TABLET | Discontinued | 2018-02-23 | 2018-12-28 | 40854 |
| APO-SALVENT TABLETS - 4MG | 4MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40847 |
| APO-SERTRALINE | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-09-15 | 60781 |
| APO-SILDENAFIL | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60784 |
| APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
| APO-SIMVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60790 |
| APO-SIMVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-11-19 | 60793 |
| APO-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78269 |
| APO-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78272 |